Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1992 Jul;34(1):25–31. doi: 10.1111/j.1365-2125.1992.tb04103.x

Captopril augments both basal and frusemide-induced natriuresis in normal man by suppression of circulating angiotensin II.

J G Motwani 1, A D Struthers 1
PMCID: PMC1381371  PMID: 1633064

Abstract

1. We studied the renal effects of reinfusing low dose angiotensin II (1 ng kg-1 min-1) into seven salt-replete healthy volunteers after pretreatment with the angiotensin converting enzyme (ACE) inhibitor captopril (25 mg) to establish whether the natriuretic and renal haemodynamic responses to ACE inhibition in normal man result from suppression of circulating angiotensin II. In the same subjects we also studied the effect of captopril (25 mg) with and without exogenous angiotensin II (1 ng kg-1 min-1) on the natriuretic response to intravenous frusemide (20 mg). 2. In the pre-frusemide study captopril increased absolute and fractional excretion of sodium and paraaminohippurate clearance but had no effect on inulin clearance. 3. Reinfusion of angiotensin II after captopril pretreatment completely suppressed the renal effects of ACE inhibition, yielding renal vasoconstrictor and antinatriuretic effects equivalent to those produced by infused angiotensin II in the absence of captopril. 4. Frusemide increased renal sodium excretion without affecting paraaminohippurate or inulin clearance. Captopril augmented frusemide-induced natriuresis and again this effect was reversed by angiotensin II reinfusion. 5. We conclude that captopril augments both basal and frusemide-induced renal sodium excretion in normal man. Our findings suggest that these renal responses to ACE inhibition may be mediated by inhibition of circulating angiotensin II, specifically its renal tubular salt-retaining actions, rather than via effects on other neurohumoral systems.

Full text

PDF
25

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brater D. C. Analysis of the effect of indomethacin on the response to furosemide in man: effect of dose of furosemide. J Pharmacol Exp Ther. 1979 Sep;210(3):386–390. [PubMed] [Google Scholar]
  2. Brown M. J., Jenner D. A. Novel double-isotope technique for enzymatic assay of catecholamines, permitting high precision, sensitivity and plasma sample capacity. Clin Sci (Lond) 1981 Nov;61(5):591–598. doi: 10.1042/cs0610591. [DOI] [PubMed] [Google Scholar]
  3. Chiu P. J., Brown A. D., Barnett A. Inhibitory effect of captopril on renal responses to frusemide in sodium-restricted rats. J Pharm Pharmacol. 1984 Jan;36(1):31–35. doi: 10.1111/j.2042-7158.1984.tb02982.x. [DOI] [PubMed] [Google Scholar]
  4. Clappison B. H., Anderson W. P., Johnston C. I. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition. Kidney Int. 1981 Nov;20(5):615–620. doi: 10.1038/ki.1981.184. [DOI] [PubMed] [Google Scholar]
  5. Di Nicolantonio R., Morgan T. O. Captopril attenuates diuretic and natriuretic actions of furosemide but not atrial natriuretic peptide. Clin Exp Hypertens A. 1987;9(1):19–32. doi: 10.3109/10641968709160028. [DOI] [PubMed] [Google Scholar]
  6. Fujimura A., Ebihara A. Role of angiotensin II in renal prostaglandin E2 production after furosemide administration. Hypertension. 1988 May;11(5):491–494. doi: 10.1161/01.hyp.11.5.491. [DOI] [PubMed] [Google Scholar]
  7. Kelly R. A., Wilcox C. S., Mitch W. E., Meyer T. W., Souney P. F., Rayment C. M., Friedman P. A., Swartz S. L. Response of the kidney to furosemide. II. Effect of captopril on sodium balance. Kidney Int. 1983 Aug;24(2):233–239. doi: 10.1038/ki.1983.149. [DOI] [PubMed] [Google Scholar]
  8. MacDonald T. M., Craig K., Watson M. L. Frusemide, ACE inhibition, renal dopamine and prostaglandins: acute interactions in normal man. Br J Clin Pharmacol. 1989 Dec;28(6):683–694. doi: 10.1111/j.1365-2125.1989.tb03561.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. MacFadyen R. J., Lees K. R., Reid J. L. Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs. Br J Clin Pharmacol. 1991 Jan;31(1):1–13. doi: 10.1111/j.1365-2125.1991.tb03851.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. MacGregor G. A., Markandu N. D., Roulston J. E., Jones J. C., Morton J. J. The renin--angiotensin--aldosterone system in the maintenance of blood pressure, aldosterone secretion and sodium balance in normotensive subjects. Clin Sci (Lond) 1980 Dec;59 (Suppl 6):95s–99s. doi: 10.1042/cs059095s. [DOI] [PubMed] [Google Scholar]
  11. Mackay I. G., Muir A. L., Watson M. L. Contribution of prostaglandins to the systemic and renal vascular response to frusemide in normal man. Br J Clin Pharmacol. 1984 May;17(5):513–519. doi: 10.1111/j.1365-2125.1984.tb02383.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Reams G., Villarreal D., Bauer J. H. Intrarenal metabolism of angiotensin II. Am J Physiol. 1990 Jun;258(6 Pt 2):F1510–F1515. doi: 10.1152/ajprenal.1990.258.6.F1510. [DOI] [PubMed] [Google Scholar]
  13. Toussaint C., Masselink A., Gentges A., Wambach G., Bönner G. Interference of different ACE-inhibitors with the diuretic action of furosemide and hydrochlorothiazide. Klin Wochenschr. 1989 Nov 17;67(22):1138–1146. doi: 10.1007/BF01726115. [DOI] [PubMed] [Google Scholar]
  14. Usberti M., Di Minno G., Ungaro B., Cianciaruso B., Federico S., Ardillo G., Gargiulo A., Martucci F., Pannain M., Cerbone A. M. Angiotensin II inhibition with captopril on plasma ADH, PG synthesis, and renal function in humans. Am J Physiol. 1986 Jun;250(6 Pt 2):F986–F990. doi: 10.1152/ajprenal.1986.250.6.F986. [DOI] [PubMed] [Google Scholar]
  15. de Leeuw P. W., van Es P. N., Looman M., Birkenhäger W. H. Renal response to converting enzyme blockade. J Hypertens Suppl. 1985 Dec;3(3):S295–S296. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES